UBS raised the firm’s price target on Nutrien (NTR) to $64 from $56 and keeps a Neutral rating on the shares. The firm continues to expect medium-term declines across NPK pricing, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Nutrien price target raised to $62 from $59 at Wells Fargo
- Nutrien price target raised to $70 from $65 at RBC Capital
- CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
- Nutrien downgraded to Hold from Buy at Jefferies
- Nutrien’s Short-term Gains and Long-term Challenges: A Hold Rating Amid Supply Disruptions and Structural Headwinds